AI-assisted, human-published
01/16/2025 /Funding Events
GT Medical Technologies Secures $37M in Series D Financing Round Led by Evidity Health Capital
Evidity Health Capital leads the $37 million Series D financing round for GT Medical Technologies, accelerating clinical studies and commercialization of GammaTile®. The company aims to finalize a second close of the round in Q1 2025 to meet increasing demand for GammaTile Therapy.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com